Literature DB >> 7821184

Interference of dapsone in HbA1c monitoring of a type I diabetic patient with necrobiosis lipoidica.

M Bertholon, A Mayer, A Francina, C H Thivolet.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7821184     DOI: 10.2337/diacare.17.11.1364a

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  2 in total

1.  Falsely Decreased HbA1c in a Type 2 Diabetic Patient Treated with Dapsone.

Authors:  Arti D Shah; Rena K Fox; Robert J Rushakoff
Journal:  Endocr Pract       Date:  2014-11       Impact factor: 3.443

2.  Unexpectedly low HbA1c levels in two diabetes patients following dapsone use.

Authors:  Ranjit Unnikrishnan; Ranjit Mohan Anjana; Ramamurthy Jayashri; Viswanathan Mohan
Journal:  Indian J Endocrinol Metab       Date:  2012-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.